Teriflunomide

Back to search

Molecule Structure

Scientific Name

Teriflunomide

Description of the Drug

Teriflunomide is a pyrimidine synthesis inhibitor with anti-inflammatory and immunomodulatory properties used to treat patients with the relapsing-remitting form of multiple sclerosis.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08880

Brand Name(s)

Aubagio

Company Owner(s)

Amneal Pharmaceuticals Co Gmbh, Glenmark Pharmaceuticals Inc, Msn Laboratories Private Ltd, Teva Pharmaceuticals Usa Inc, Alembic Pharmaceuticals Ltd, Apotex Inc, Sandoz Inc, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Sola Pharmaceuticals, Accord Healthcare Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Dihydroorotate dehydrogenase SINGLE PROTEIN INHIBITOR CHEMBL1966

Unichem Links

SureChEMBL SCHEMBL22661
DrugBank DB08880
PubChem: Thomson Pharma 15221873
PubChem 54684141
Nikkaji J994.777I J690.639G
PDBe A26
BindingDB 50018011
EPA CompTox Dashboard DTXSID80893457
DrugCentral 4634
Metabolights MTBLC68540
Brenda 147806 6758 55910 163092
ChemicalBook CB5648113 CB6464433 CB02486749
Guide to Pharmacology 6844
rxnorm AUBAGIO TERIFLUNOMIDE
PubChem: Drugs of the Future 12014666
ChEBI 68540
ZINC ZINC000013512456